Solventum Corp | SOLV - Ebit

Aktienkurs
74.26
Täglich Wechseln
-0.16 -0.22%
Monatlich
7.81%
Jährlich
0.20%
Q2 Prognose
72.77




Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
Align Technology USD 178.05M 46.66M 2026-03
Baxter International USD 66M 280.2M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Cencora USD 1.02B 1.09B 2025-12
Dexcom USD 255.3M 67.7M 2026-03
Insulet USD 122M 24.3M 2026-03
Solventum Corp USD 85M 20M 2026-03
West Pharmaceutical Services USD 177.1M 14.6M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03